Neonatal abstinence syndrome management: A quality improvement initiative to educate caregivers, & providers in the outpatient setting Nguyen J, MD*. Chau.

Slides:



Advertisements
Similar presentations
Management of Drug Formulary Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 06/16/06.
Advertisements

Patient Navigation Breast Health Patient Navigator Program.
Transitional Care Post Discharge; Tracking and Documentation.
{ ADVERSE DRUG REACTIONS To ensure patient, family/caregiver and home health personnel are instructed to identify adverse reactions to medications and.
Neonatal Abstinence Project Medical Guidelines Committee Kentucky NAS Workgroup Amy Snell.
V.Sideri, C.Vliora, A.Daskalaki, P.Mexi-Bourna, K.Kleanthous, M.Soulioti, G. Kyrkou, N.Bournas, V.Papaevangelou 3 rd Pediatric Clinic of the University.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
IMPACTS OF PHARMACIST’S ROLES ON REDUCING READMISSION RATE AND PROMOTING PATIENT SAFETY IN PEDIATRIC CARDIAC PATIENTS Manita Suriyarangsee Monwarat Laohajeeraphan.
RENI PRIMA GUSTY, SK.p,M.Kes
Medication Reconciliation Veterans Affairs North Texas Health Care System March 2008.
Vanderbilt Pediatric Hematology Anticoagulation Guidance Protocol Robert F. Sidonio, Jr. MD, MSc. 4/12/12 Warfarin Monitoring If inpatient, consider monitoring.
Heart Failure Core Measures GMEC QI Presentation.
Request for Social Hold in Pediatrics Policy Updates TX-383 Pam Sanders, MSN, RNC-NIC, CENP Vice President, Women & Children’s Services.
Australian Commission on Safety and Quality in Health Care
Luis Maldonado, MD, MPH, FAAP 1 ; Cindy Morris 2 ; Marybeth Palmigiano, MPH 3 ; Lynn Ringenberg, MD, FAAP 1 University of South Florida Department of Pediatrics,
BACKGROUND Health Care Attitudes and Trends among the Pediatric Prescribing Community Mahesh Narayan 1 MB, MSE, Dimple Patel 1 MS, Peter C. Adamson 1,2,3.
Bryan Bray, Pharm.D., CPP Chief Operating Officer Medication Management, LLC Vice President of Clinical Services Piedmont Pharmaceutical Care Network,
BPI MEDICAID Certification Review Process and Federal Requirements.
Clinical Pharmacy Part 2
Achieving Glycemic Control in the Hospital Setting Part 4 of 4.
1 Module 7 Discharge Planning Managing the Transition from Inpatient to Outpatient Care Diabetes Special Interest Group Georgia Hospital Association.
Treatment of Opioid Dependency in Pregnancy and Strategies to Reduce Neonatal Abstinence Syndrome.
ST ELEVATION MYOCARDIAL INFARCTION (STEMI) PATIENT DISCHARGE INSTRUCTION CHECKLIST: CAN WE DO BETTER? Maryann Rabusic-Wiedener, Shauna Johns, Tina Ainsworth,
Case Management. 2 Case Management Defined Assists an individual in gaining and coordinating access to necessary care and services appropriate to the.
CHF Team Approach Peter Carson, MD Jacqueline Gannuscio, MSN, ACNP RN Washington DC.
Readmissions Driver Diagram OHA HEN 2.0. Readmissions AIMPrimary Drivers Secondary DriversChange Ideas Reduce Readmissions Identify patients at high-risk.
NSTEMI Pathway Education for Nurses. Objectives Demonstrate an understanding of the NSTEMI clinical pathway. Understand the importance of early and consistent.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
Development of a Community Stroke Rehabilitation Team “meeting the need” NHS Blackburn with Darwen Tracy Walker Team Leader.
Purpose Of Training: To guide Clinicians in the completion of screens and development of Alternative Community Service Plans.
HEART FAILURE TEAM MEMBERSHIP DEPARTMENTS OF CARDIOLOGY, CARDIOVASCULAR SURGERY, MEDICINE, NURSING, QUALITY AND RESOURCE MANAGEMENT, THE CENTER FOR CLINICAL.
Health care delivery systems Dr. Aidah Alkaissi. Types of health care There are three types of services which:- 1. Health promotion and illness prevention.
University of South Florida Department of Pediatrics, Tampa, FL
Effects of Case Management on Frequent
MULTI DISPLINARY CARE.. . PATIENT PHYSICIANNURSESOTHERSDIETITIANPHYSIOTHERAPIST.
CJR McLeod Regional Medical Center
The Nursing Process and Drug Therapy
Neonatal Abstinence Syndrome (NAS) Program Overview
Screening and Referral
Associate Professor of Pediatrics, USF FPQC MOM Initiative Kick-off
Jessica Lobban, PGY-3 CCLP Family Medicine Residency Program
Neonatal Abstinence Syndrome: An emerging issue for Part C systems?
EARLY SUPPORTED DISCHARGE FOR STROKE PATIENTS
Improving Care for Opioid-Exposed Newborns
Supplementary Prescribing in a neonatal ICU
A Recommendation from Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from ACOP and APS By Rhys Dela Cruz, Angela Hickey,
Medication Assisted Treatment and Pregnancy
Engaging a Microsystem to Reduce 30-Day Readmissions on an Acute Care Unit Erin Johnson, MSN, RN, Sara Stetz, MSN, RN.
Defining Best Practice:
April 12, 2017 Guy Reese, Program Integrity Manager
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
HEART FAILURE TEAM MEMBERSHIP
Community Step Up Program
Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD
Provider and Member Education in Managed Care Pharmacy
WisPQC Standardized Protocol Webinar for NAS/NOWS Initiative
Length of Stay Reduction Project – UMMCH Unit 6
GHS Outpatient Enoxaparin Program
Principal recommendations
BoRN ADDICTED: Neonatal Abstinence syndrome
Optum’s Role in Mycare Ohio
30-40% of pregnant women receive opioid
Jonathan Davis, MD Chief of Newborn Medicine
Introduction to Clinical Pharmacology Chapter 4 The Nursing Process
April 6th 2017 Presented By: Shanelle Van Dyke
Neonatal Abstinence Syndrome Survey
March 23rd 2017 Presented By: Shanelle Van Dyke
Florida AHRMM Summer Conference Legislative Briefing
Dr. Sarah Fernandez PGY4 NOSM, Pediatrics, Thunder Bay Campus
Principal recommendations
Presentation transcript:

Neonatal abstinence syndrome management: A quality improvement initiative to educate caregivers, & providers in the outpatient setting Nguyen J, MD*. Chau K, DO*. Lilly C, MD. Ashmeade TL, MD. Balakrishnan M, MD. University of South Florida at Tampa General Hospital, Tampa, FL. BACKGROUND METHODS The U.S. incidence of antenatal drug use & Neonatal Abstinence Syndrome (NAS) has increased with >50% of opioid exposed infants developing NAS. NAS is associated w/prolonged hospital length of stay & increased health care costs. Outpatient medical management for NAS may decrease health care costs. Little is known related to: Parents response to coordinated inpatient & outpatient interventions for NAS Outpatient healthcare provider level of knowledge & comfort w/NAS management INTERVENTIONS Cycle 1: 6/11/13 to 9/19/13 Developed JNFP comprehensive discharge planning Developed & implemented tools for providers: NAS outpatient management guideline, methadone dose adjustment algorithm, EMR note template Developed & implemented tools for parents: erasable magnetic tablet for care plan, NAS symptom diary Standardized methadone concentration & prescription instructions for providers Developed provider education curriculum (USF Pediatric attendings, residents, nurse practitioners) Cycle 2: 9/20/13 to 12/11/13 Revised NAS guideline: scheduled minimum 4 follow-up appointments, increased % of weans, encouraged wean at first outpatient appointment Revised NAS EMR template to improve efficiency Developed clinic NAS poster for healthcare providers: prompting survey distribution, providing management tips, pharmacy contact information Placed reminder sticker on NAS symptom diary to bring diary to each appointment Confirmed 3 local pharmacies consistently stocked prescribed methadone concentration Cycle 3: 12/12/13 to 4/30/14 TGH’s occupational therapy handouts available in outpatient clinics (e.g. positioning techniques, swaddling instructions, range of motion exercises). Included consideration of outpatient counseling by mother when deciding social work’s clearance of infant for outpatient methadone management NAS Outpatient Weaning Algorithm OBJECTIVES Use a multi-disciplinary approach in NAS management to improve consistency of care RESULTS Primary Describe our center’s comprehensive outpatient NAS management program Assess the program’s safety (defined as <10% requiring hospital readmission) Achieve healthcare provider compliance w/the program: 1. >75% compliance w/outpatient management guideline 2. >75% of healthcare providers using EMR note template Secondary Describe duration & cumulative dose of outpatient methadone exposure >75% of healthcare providers & parents having improved knowledge & attitudes towards NAS After implementation* 100% of parents responded being comfortable: 1.Caring for & soothing their NAS infant 2. Administering methadone to their infant 3.Understanding the diagnosis of NAS prior to delivery 4. Comfort level in identifying NAS signs & symptoms 5. Finding medical team helpful in providing anticipatory guidance There was no significant difference in helpfulness of NAS educational materials. *Parent survey response rates: #1 at pre-implementation: 100% (n=5), #2 at 1st appointment: 73% (n=22), #3 at appointment when methadone discontinued: 40% (n=20) Input measure Parent compliance in bringing NAS symptom diary to pediatric appointments Process measure Healthcare provider compliance w/NAS outpatient management guidelines & EMR template Outcome measure Duration of outpatient methadone treatment Cumulative dose methadone exposure Balancing Appropriate weight gain (>20 g/day) Hospital readmissions for NAS management Total # surveys distributed: 67 Description of input & process measures. Cycle 1a (N=97) Cycle 2a (N=124) Cycle 3a (N=82) All cyclesa (N=303) Outpatient methadone algorithm compliance, n (%) 65(67) 90(73) 58(71) 213(70) EMR template used, n (%) 76(78) 96(77) 60(73) 232(77) Infant weight assessment documented in EMR, n (%) 83(86) 109(88) 65(79) 257(87) NAS symptoms documented in EMR, n (%) 91(94) 120(97) 81(99) 292(96) Current dose documented in EMR, n (%) 89(92) 112(90) 74(90) 263(87) NAS symptom diary brought to pediatric clinic appointment, n (%) 43(44) 62(50) 52(63) 157(52) N: number of appointments in each cycle. aDate of NICU discharge determines which cycle infants are included. SETTING TGH is an academic medical center with ~ 5,500 deliveries/year ~70 NICU admits/year for NAS diagnosis ~20 infants/year d/c w/outpatient management USF/TGH Joint Neonatal Follow-up Program (JNFP) uses methadone for outpatient NAS management USF/TGH’s NICU NAS infants may be discharged for outpatient management if: 1. Controlled NAS symptoms on methadone ≤0.16 mg/kg/day once daily 2. Cleared by TGH social work Inclusion criteria: NAS infants discharged from USF/TGH NICU for outpatient methadone management w/USF Pediatric follow-up. DISCUSSION A multidisciplinary approach to outpatient NAS management can: Be safe when a comprehensive management program is implemented Result in appropriate infant weight gain Demonstrate healthcare provider compliance w/an outpatient management guideline & EMR template Improve parent & provider knowledge & attitudes regarding care of a NAS infant More research is needed to determine the long term effects of cumulative methadone dose exposure & duration of exposure on infant outcomes. Description of outcome & balancing measures. Cycle 1a (N=4) Cycle 2a (N=10) Cycle 3a (N=6) All cyclesa (N=20) Number of pediatric clinic appointments for NAS, average (range) 8 (4-13) 9 (5-20) 11 (7-13) 10 (4-20) Total duration of methadone from NICU discharge to time methadone discontinued in cycle, days±SD (range) 58.8±15.2 (40-80) 61.8±27.5 (32-132) 69.7±12.6 (46-86) 63.6±22.1 (32-132) Average NICU discharge dose of methadone, mg±SD 0.35±0.08 0.39±0.13 0.45±0.08 0.4 ± 0.11 Average dose at methadone discontinuation, mg±SD 0.13±0.04 0.11±0.02 0.11±0.01 0.11±0.03 Average outpatient cumulative methadone dose from NICU discharge to time methadone discontinued in cycle, mg±SD 13.6±5.8 15.6 ± 9.8   16.8±4 15.6±7.8 Weight (g) at first pediatric clinic appointment, average (range) 3370±261 3240±536 3300±458 Average weight gain (g/day) on outpatient methadone management, mg±SD 26±9.4 29.4±9.4 31.8±3.9 29.4±8.4 Hospital readmissions for NAS management 2 N: Number of infants in each cycle. Infants who required hospital readmission & were completely weaned off of methadone during hospital admission or did not wean off of methadone before the end date of cycle 3 were excluded from this data analysis (2 infants). aDate of methadone discontinuation determines which cycle infants are included. CONTACT: mbalakri@health.usf.edu, Division of Neonatology, 1 Tampa General Circle, F170, Tampa, FL 33611